Literature DB >> 937920

Defective triglyceride removal in lipemia associated with peritoneal dialysis and haemodialysis.

D C Cattran, S S Fenton, D R Wilson, G Steiner.   

Abstract

Plasma lipids were measured in 78 uremic patients receiving either chronic peritoneal dialysis or haemodialysis. Type IV hyperlipemia was found in 60% of patients. The lipid level was not influenced by dietary habits or patient's age. Patients on chronic peritoneal dialysis had a significantly higher and more sustained hyperlipemia than the patients on haemodialysis. Triglyceride turnover studies showed that all patients, regardless of the type of dialysis or lipid level, had impaired triglyceride removal as the cause of this lipemia. This defect in triglyceride metabolism was only partially corrected by increasing the efficiency of the dialysis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 937920     DOI: 10.7326/0003-4819-85-1-29

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  13 in total

1.  Lipoprotein-apolipoprotein changes in renal transplant recipients.

Authors:  Maurizio Cassader; Gianluca Ruiu; Roberto Gambino; Natalina Alemanno; Giorgio Triolo; Fabrizio Veglia; Gianfranco Pagano
Journal:  Lipids       Date:  2002-10       Impact factor: 1.880

2.  High-density lipoprotein in chronic renal failure and after renal transplantation.

Authors:  E Savdie; J C Gibson; J H Stewart; L A Simons
Journal:  Br Med J       Date:  1979-04-07

3.  Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP1 expression.

Authors:  Nosratola D Vaziri; Jun Yuan; Zhenmin Ni; Susanne B Nicholas; Keith C Norris
Journal:  Clin Exp Nephrol       Date:  2011-10-19       Impact factor: 2.801

4.  Triglyceride turnover in health and disease.

Authors:  G Steiner
Journal:  Can Med Assoc J       Date:  1979-10-20       Impact factor: 8.262

5.  Hyperlipidaemia in uraemic patients under chronic haemodialysis. Correlation with serum lipoprotein lipase and insulin levels.

Authors:  M A Sobh; S A Shamaa; A M el-Gayar; M M el-Sharabacy
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

Review 6.  [Alterations of fat metabolism in renal disease - pathogenetic mechanisms (author's transl)].

Authors:  W H Hörl; M Hörl; A Heidland
Journal:  Klin Wochenschr       Date:  1982-04-01

7.  Protein and lipid metabolism in nephrotic infants on peritoneal dialysis after nephrectomy.

Authors:  M Antikainen
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

8.  [Reduction of post-heparin lipoprotein lipase activity by acidotic blood pH].

Authors:  C Breier; A Dzien; H J Lisch; H Braunsteiner
Journal:  Klin Wochenschr       Date:  1984-06-15

Review 9.  Lipoprotein metabolism in chronic renal insufficiency.

Authors:  Jeffrey M Saland; Henry N Ginsberg
Journal:  Pediatr Nephrol       Date:  2007-03-28       Impact factor: 3.714

Review 10.  Role of the kidney in hormone metabolism and its implications in clinical medicine.

Authors:  D S Emmanouel; M D Lindheimer; A I Katz
Journal:  Klin Wochenschr       Date:  1980-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.